Market Overview:
The global human troponin antibody market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of cardiac diseases, rising geriatric population, and technological advancements in the field of diagnostics. Based on type, the global human troponin antibody market is segmented into Troponin I Antibody, Troponin T Antibody, and Troponin C Antibody. Based on application, the global human troponin antibody market is segmented into hospital-based diagnostics, life sciences research laboratories-based diagnostics), and point-of-care testing (POC) devices. Geographically, the global human troponin antibody market is segmented into North America,, Latin America,, Europe,, Asia Pacific,, and Middle East & Africa).
Product Definition:
A human troponin antibody is a protein that is produced in response to the presence of troponin, a protein that is found in muscle tissue. The antibody binds to the troponin molecule, preventing it from interacting with other proteins and causing the muscle cells to contract. Troponin antibodies may be used as diagnostic markers for diseases such as heart attack or stroke, and can be used to monitor patients who have received treatment for these conditions.
Troponin I Antibody:
Troponin I (TnI) is a protein that facilitates the binding of myosin light chains to actin filaments. It is produced in cardiac muscle cells and bound to tropomyosine through its amino acid residue. Troponins are also known as antibradycardia proteins, they help regulate the pace of contractions within cardiac muscles by inhibiting calcium influx into cardiomyocytes through voltage-gated ion channels.
Troponin T Antibody:
Troponin T (TnT) is a protein that is found in the myocardium of cardiac muscle. It helps in detecting heart attacks and strokes more quickly than other troponins. Troponin T Antibody used for detection of cardiac-related problems such as heart attack, stroke, and others through the Enzyme-linked Immunosorbent Assay (ELISA).
Application Insights:
The hospital application segment accounted for the largest revenue share in 2017. The rise in demand for troponin tests to diagnose cardiac and neurodegenerative diseases is expected to be a major factor driving the segment growth over the forecast period. In addition, increasing number of hospitals offering advanced healthcare services coupled with rising incidences of sports-related injuries are anticipated to further boost product demand from 2018 to 2030.
The life sciences application segment is projected register a significant CAGR during the forecast period owing to growing awareness regarding various disorders including cancer and cardiovascular diseases among individuals across regions.
In addition, an increase in prevalence of chronic conditions such as cancer.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure and increasing prevalence of cardiac disorders are some factors responsible for its growth. Furthermore, the rising number of FDA approvals for new products is also expected to drive the region’s growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to improving healthcare facilities and growing awareness about early diagnosis in emerging countries such as China, India, and South Korea. Moreover, a large population base with high unmet clinical needs will propel market growth during this period.
Growth Factors:
- Increasing incidence of cardiac diseases: The increasing incidence of cardiac diseases is one of the major growth drivers for the human troponin antibody market. According to a study by the World Health Organization (WHO), an estimated 17.5 million people died from cardiovascular diseases in 2012, accounting for 31% of all global deaths. This number is expected to increase to 23 million by 2030. This growing prevalence of cardiac diseases is expected to drive demand for human troponin antibodies and related products in the coming years.
- Rising awareness about early diagnosis and treatment: There is a growing awareness among people about the importance of early diagnosis and treatment for heart-related conditions. This has led to an increase in demand for diagnostic tests that can help detect heart problems at an early stage. Human troponin antibodies are increasingly being used as biomarkers for diagnosing various types of heart disease, thereby driving market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Troponin Antibody Market Research Report
By Type
Troponin I Antibody, Troponin T Antibody, Troponin C Antibody
By Application
Hospital, Life Sciences, Laboratory
By Companies
HyTest, Medix Biochemica, Novus Biologicals, Abcam, Meridian Life Science, Thermo Fisher Scientific, Cell Signaling Technology, Lifespan Biosciences, HUABIO, Genetex, Biorbyt, Proteintech, BiosPacific, Santa Cruz Biotechnology, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Human Troponin Antibody Market Report Segments:
The global Human Troponin Antibody market is segmented on the basis of:
Types
Troponin I Antibody, Troponin T Antibody, Troponin C Antibody
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Life Sciences, Laboratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- HyTest
- Medix Biochemica
- Novus Biologicals
- Abcam
- Meridian Life Science
- Thermo Fisher Scientific
- Cell Signaling Technology
- Lifespan Biosciences
- HUABIO
- Genetex
- Biorbyt
- Proteintech
- BiosPacific
- Santa Cruz Biotechnology
- Merck
Highlights of The Human Troponin Antibody Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Troponin I Antibody
- Troponin T Antibody
- Troponin C Antibody
- By Application:
- Hospital
- Life Sciences
- Laboratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Troponin Antibody Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human troponin antibody is a protein that is produced in the body when someone has a heart attack or stroke. Troponin antibodies are used to diagnose these conditions.
Some of the major players in the human troponin antibody market are HyTest, Medix Biochemica, Novus Biologicals, Abcam, Meridian Life Science, Thermo Fisher Scientific, Cell Signaling Technology, Lifespan Biosciences, HUABIO, Genetex, Biorbyt, Proteintech, BiosPacific, Santa Cruz Biotechnology, Merck.
The human troponin antibody market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Troponin Antibody Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human Troponin Antibody Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human Troponin Antibody Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human Troponin Antibody Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human Troponin Antibody Market Size & Forecast, 2018-2028
4.5.1 Human Troponin Antibody Market Size and Y-o-Y Growth
4.5.2 Human Troponin Antibody Market Absolute $ Opportunity
Chapter 5 Global Human Troponin Antibody Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Human Troponin Antibody Market Size Forecast by Type
5.2.1 Troponin I Antibody
5.2.2 Troponin T Antibody
5.2.3 Troponin C Antibody
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Human Troponin Antibody Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Human Troponin Antibody Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Life Sciences
6.2.3 Laboratory
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human Troponin Antibody Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human Troponin Antibody Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Human Troponin Antibody Analysis and Forecast
9.1 Introduction
9.2 North America Human Troponin Antibody Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Human Troponin Antibody Market Size Forecast by Type
9.6.1 Troponin I Antibody
9.6.2 Troponin T Antibody
9.6.3 Troponin C Antibody
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Human Troponin Antibody Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Life Sciences
9.10.3 Laboratory
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Human Troponin Antibody Analysis and Forecast
10.1 Introduction
10.2 Europe Human Troponin Antibody Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Human Troponin Antibody Market Size Forecast by Type
10.6.1 Troponin I Antibody
10.6.2 Troponin T Antibody
10.6.3 Troponin C Antibody
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Human Troponin Antibody Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Life Sciences
10.10.3 Laboratory
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Human Troponin Antibody Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Human Troponin Antibody Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Human Troponin Antibody Market Size Forecast by Type
11.6.1 Troponin I Antibody
11.6.2 Troponin T Antibody
11.6.3 Troponin C Antibody
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Human Troponin Antibody Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Life Sciences
11.10.3 Laboratory
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Human Troponin Antibody Analysis and Forecast
12.1 Introduction
12.2 Latin America Human Troponin Antibody Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Human Troponin Antibody Market Size Forecast by Type
12.6.1 Troponin I Antibody
12.6.2 Troponin T Antibody
12.6.3 Troponin C Antibody
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Human Troponin Antibody Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Life Sciences
12.10.3 Laboratory
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Human Troponin Antibody Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Human Troponin Antibody Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Human Troponin Antibody Market Size Forecast by Type
13.6.1 Troponin I Antibody
13.6.2 Troponin T Antibody
13.6.3 Troponin C Antibody
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Human Troponin Antibody Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Life Sciences
13.10.3 Laboratory
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human Troponin Antibody Market: Competitive Dashboard
14.2 Global Human Troponin Antibody Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 HyTest
14.3.2 Medix Biochemica
14.3.3 Novus Biologicals
14.3.4 Abcam
14.3.5 Meridian Life Science
14.3.6 Thermo Fisher Scientific
14.3.7 Cell Signaling Technology
14.3.8 Lifespan Biosciences
14.3.9 HUABIO
14.3.10 Genetex
14.3.11 Biorbyt
14.3.12 Proteintech
14.3.13 BiosPacific
14.3.14 Santa Cruz Biotechnology
14.3.15 Merck
